Matthew Kahn

1.2k total citations
22 papers, 437 citations indexed

About

Matthew Kahn is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matthew Kahn has authored 22 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matthew Kahn's work include Heart Failure Treatment and Management (6 papers), Cardiac pacing and defibrillation studies (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Matthew Kahn is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Cardiac pacing and defibrillation studies (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Matthew Kahn collaborates with scholars based in United Kingdom, United States and South Africa. Matthew Kahn's co-authors include Richard M. Cubbon, Stephen B. Wheatcroft, Mark T. Kearney, Adil Rajwani, Afroze Abbas, Hema Viswambharan, Helen Imrie, Matthew Gage, Peter J. Grant and Piruthivi Sukumar and has published in prestigious journals such as Circulation, Diabetes and Endocrinology.

In The Last Decade

Matthew Kahn

21 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Kahn United Kingdom 12 183 156 120 78 68 22 437
Rodolfo Nasti Italy 9 126 0.7× 134 0.9× 115 1.0× 42 0.5× 100 1.5× 14 422
Evanthia Bletsa Greece 10 154 0.8× 109 0.7× 138 1.1× 70 0.9× 67 1.0× 33 460
Jayshree Acharya United Kingdom 14 152 0.8× 114 0.7× 112 0.9× 80 1.0× 147 2.2× 20 511
Eleonora Devangelio Italy 6 109 0.6× 85 0.5× 121 1.0× 40 0.5× 50 0.7× 6 387
Cosimo Sacra Italy 13 350 1.9× 126 0.8× 146 1.2× 43 0.6× 134 2.0× 29 604
Sarah Eder Austria 7 285 1.6× 112 0.7× 141 1.2× 30 0.4× 59 0.9× 13 491
Jessica Nigro United States 5 161 0.9× 219 1.4× 90 0.8× 86 1.1× 40 0.6× 7 455
Pasquale Petronella Italy 9 111 0.6× 128 0.8× 139 1.2× 31 0.4× 97 1.4× 28 445
Hamish Walker United Kingdom 10 140 0.8× 169 1.1× 80 0.7× 114 1.5× 53 0.8× 25 604
K. Rajeshwar India 10 100 0.5× 84 0.5× 86 0.7× 40 0.5× 44 0.6× 11 384

Countries citing papers authored by Matthew Kahn

Since Specialization
Citations

This map shows the geographic impact of Matthew Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Kahn more than expected).

Fields of papers citing papers by Matthew Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Kahn. The network helps show where Matthew Kahn may publish in the future.

Co-authorship network of co-authors of Matthew Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Kahn. A scholar is included among the top collaborators of Matthew Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Kahn. Matthew Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kahn, Matthew, et al.. (2025). Evaluation of real-world application of cardiac implantable electronic device-based multi-sensor algorithm for heart failure management. European Heart Journal - Digital Health. 6(3). 427–434.
2.
Ahmed, Fozia, Glen P. Martin, Matthew Kahn, et al.. (2024). Association of a Device-Based Remote Management Heart Failure Pathway with Outcomes: TriageHF Plus Real-World Evaluation. ESC Heart Failure. 11(5). 2637–2647. 8 indexed citations
3.
Walker, Lauren, Matthew Kahn, Archana Rao, et al.. (2022). Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance. Open Heart. 9(2). e001979–e001979. 16 indexed citations
6.
Walker, Lauren, et al.. (2021). 132 One year outcomes of heart failure multispecialty multidisciplinary team virtual meetings. A99.1–A99. 1 indexed citations
8.
Chakravarty, Dimple, Li Huang, Matthew Kahn, & Ashutosh Tewari. (2020). Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options. Urologic Clinics of North America. 47(4). 487–510. 11 indexed citations
9.
Cubbon, Richard M., Andrew Woolston, Chris P Gale, et al.. (2014). Prospective development and validation of a model to predict heart failure hospitalisation. Heart. 100(12). 923–929. 43 indexed citations
10.
Abbas, Afroze, Hema Viswambharan, Helen Imrie, et al.. (2011). A Endothelial cell nitric oxide bioavailability and insulin sensitivity are regulated by IGF-1 and insulin receptor levels. Heart. 97(Suppl 1). A1–A2. 1 indexed citations
11.
Abbas, Afroze, Helen Imrie, Hema Viswambharan, et al.. (2011). The Insulin-Like Growth Factor-1 Receptor Is a Negative Regulator of Nitric Oxide Bioavailability and Insulin Sensitivity in the Endothelium. Diabetes. 60(8). 2169–2178. 68 indexed citations
12.
Kahn, Matthew, Richard M. Cubbon, Ben Mercer, et al.. (2011). Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era. Diabetes and Vascular Disease Research. 9(1). 3–9. 26 indexed citations
13.
Kahn, Matthew, Nadira Yuldasheva, Richard M. Cubbon, et al.. (2011). Insulin Resistance Impairs Circulating Angiogenic Progenitor Cell Function and Delays Endothelial Regeneration. Diabetes. 60(4). 1295–1303. 42 indexed citations
14.
Murgatroyd, Scott R., Carrie Ferguson, Mark Rakobowchuk, et al.. (2010). 020 Human exercise induced circulating progenitor cell mobilisation is nitric oxide dependent and is blunted in South Asian men. A14.1–A14. 2 indexed citations
15.
Cubbon, Richard M., Scott R. Murgatroyd, Carrie Ferguson, et al.. (2010). Human Exercise-Induced Circulating Progenitor Cell Mobilization Is Nitric Oxide-Dependent and Is Blunted in South Asian Men. Arteriosclerosis Thrombosis and Vascular Biology. 30(4). 878–884. 51 indexed citations
16.
Cubbon, Richard M., Matthew Kahn, & Stephen B. Wheatcroft. (2009). Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clinical Science. 117(5). 173–190. 64 indexed citations
17.
Imrie, Helen, Afroze Abbas, Hema Viswambharan, et al.. (2009). Vascular Insulin-Like Growth Factor-I Resistance and Diet-Induced Obesity. Endocrinology. 150(10). 4575–4582. 42 indexed citations
18.
Abbas, Afroze, Helen Imrie, Hema Viswambharan, et al.. (2008). Abstract 3671: Dietary-induced Obesity in Mice results in Metabolic and Vascular Insulin-like Growth Factor 1 Resistance. Circulation. 118. 1 indexed citations
19.
Cubbon, Richard M., Matthew Kahn, & Mark T. Kearney. (2007). Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective. International Journal of Clinical Practice. 62(2). 287–299. 16 indexed citations
20.
Dardik, Herbert, et al.. (1981). Morphologic structure of the pedal arch and its relationship to patency of crural vascular reconstruction.. PubMed. 152(5). 645–8. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026